INCOG BioPharma Services
PrivateLast Round
Grant
Dec 16, 2025
Total Funding Raised
$57.86M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
INCOG BioPharma Services is a contract development and manufacturing organization (CDMO) that provides end-to-end services for sterile injectable drug products for the global biopharmaceutical market. Founded in 2020, the company supports biopharmaceutical partners from clinical through commercial stages. Its services include injectable drug product formulation, analytical method development, process scale-up, and the filling of vials, syringes, and cartridges. INCOG also offers customized packaging, device assembly, and integrated storage solutions. The company operates out of an FDA-approved, 90,000 sq. ft. facility in Fishers, Indiana, and is actively expanding its capacity to meet growing market demand.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
INCOG BioPharma Services Comparables
Compare INCOG BioPharma Services with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| August Bioservices | 90% | |
| Grand River Aseptic Manufacturing | 88% | |
| Simtra BioPharma Solutions | 88% |
INCOG BioPharma Services Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 16, 2025 | ||||
| Series C | May 29, 2024 | ||||
| Debt | May 10, 2022 | ||||
| Series B | Apr 26, 2022 |
Key People
Founding team and executive leadership
INCOG BioPharma Services Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| City of Fishers | Grant |
| Indiana Economic Development Corporation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
Grew 26% QoQ, from 348 to 440 employees.
- Aug 1, 2026
Grew 19% QoQ, from 348 to 413 employees.
INCOG BioPharma Services Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access